Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-10-01 17:04 |
Compugen To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple…
|
English | 86.3 KB | ||
| 2021-10-01 17:04 |
Compugen To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple…
|
English | 35.9 KB | ||
| 2021-09-14 15:59 |
Compugen to Present at the Cantor Global Healthcare
Conference
|
English | 82.9 KB | ||
| 2021-09-14 15:59 |
Compugen to Present at the Cantor Global Healthcare
Conference
|
English | 35.9 KB | ||
| 2021-09-03 01:04 |
6K: On September 2, 2021 the “Company held its 2021 Annual General Meeting of S…
|
English | 61.7 KB | ||
| 2021-09-03 01:04 |
6K: On September 2, 2021 the “Company held its 2021 Annual General Meeting of S…
|
English | 35.8 KB | ||
| 2021-08-26 15:59 |
Present at the Morgan Stanley 19th Annual Global Healthcare Conference
|
English | 83.4 KB | ||
| 2021-08-26 15:59 |
Present at the Morgan Stanley 19th Annual Global Healthcare Conference
|
English | 35.8 KB | ||
| 2021-08-19 15:59 |
Compugen Announces Bispecific Antibody Derived from
COM902 to Enter Clinical D…
|
English | 98.5 KB | ||
| 2021-08-19 15:59 |
Compugen Announces Bispecific Antibody Derived from
COM902 to Enter Clinical D…
|
English | 35.9 KB | ||
| 2021-07-29 15:59 |
Immediate Report of Meeting to be held on September 2, 2021
|
English | 123.5 KB | ||
| 2021-07-29 15:59 |
Immediate Report of Meeting to be held on September 2, 2021
|
English | 134.0 KB | ||
| 2021-07-28 15:59 |
Compugen Reports Second Quarter 2021 Results
|
English | 227.6 KB | ||
| 2021-07-28 15:59 |
Compugen Reports Second Quarter 2021 Results
|
English | 35.8 KB | ||
| 2021-07-19 15:59 |
First Patient in Phase 1/2 Triple Combination Cohort
Expansion of COM701 with …
|
English | 103.6 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
